Diabetes Clinical Trials in San Diego, CA

64 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection	—	Optain Health	<1 mi
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age	N/A	Scripps Whittier Diabetes Institute	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis	Phase 2/3	CSL Behring	<1 mi
Project Dulce for Filipino-Americans With Type 2 Diabetes	N/A	Scripps Whittier Diabetes Institute	<1 mi
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM	N/A	Scripps Whittier Diabetes Institute	<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	<1 mi
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population	N/A	San Diego State University	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Efficacy of Using Mobile Health Applications for Health	N/A	San Diego State University	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
More Fresh Fruit and Vegetable Prescription Program for Families With Type 2 Diabetes Mellitus	N/A	University of California, San Diego	<1 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	<1 mi
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	<1 mi
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes	Phase 2	Scripps Whittier Diabetes Institute	<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	<1 mi
Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes	N/A	University of California, San Diego	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	<1 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	<1 mi
Dosimetry of Tc-99m-Tilmanocept	Phase 1	University of California, San Diego	<1 mi
Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults	N/A	San Diego State University	<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
Implementing Food Referrals for Equity and Sustained Health	Phase 2	University of California, San Diego	<1 mi
MiniMed Fit Payload Wear Study	—	Medtronic Diabetes	7 mi
Latinos Understanding the Need for Adherence in Diabetes Using E-Health	N/A	San Diego State University	7 mi
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)	Phase 1	Merck Sharp & Dohme LLC	7 mi
A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500	Phase 1	Portal Diabetes, Inc.	7 mi
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	7 mi
Different Doses of Naronapride Vs. Placebo in Gastroparesis	Phase 2	Dr. Falk Pharma GmbH	7 mi
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus	Phase 1	Amgen	7 mi
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)	Phase 1	Merck Sharp & Dohme LLC	7 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	7 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	9 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	10 mi
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes	Phase 2	Hoffmann-La Roche	10 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	10 mi
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin	Phase 2	Eli Lilly and Company	10 mi
Closed Loop and Education for Hypoglycemia Awareness Restoration	N/A	Milton S. Hershey Medical Center	11 mi
Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health	Phase 2	University of California, San Diego	11 mi
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes	Phase 1/2	University of California, San Diego	11 mi
Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7	N/A	Scripps Whittier Diabetes Institute	11 mi
Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial	Phase 2	University of California, San Diego	11 mi
Time-Restricted Eating for Type II Diabetes: TRE-T2D	N/A	University of California, San Diego	11 mi
THC Effects on Glucose in Type 2 Diabetes	Phase 1	University of California, San Diego	11 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	11 mi
Project Dulce for Arab Americans With Type 2 Diabetes	N/A	Scripps Whittier Diabetes Institute	13 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes	Phase 3	Eli Lilly and Company	28 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	28 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	28 mi
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes	Phase 3	Kailera	28 mi
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM	N/A	i-SENS, Inc.	28 mi
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature	N/A	Senseonics, Inc.	28 mi
A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's	N/A	Compedica Inc	34 mi
EDX110 Randomized Control Trial for Treatment of DFUs	N/A	ConvaTec Inc.	34 mi
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management	N/A	Legacy Medical Consultants	34 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers	N/A	LifeNet Health	34 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	34 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	N/A	Tides Medical	34 mi
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC	N/A	Surgenex	34 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.